Jump Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
1,347,112
+1,198,263
| +805% | +$10.7M | 0.13% | 190 |
|
|
2025
Q1 | $1.12M | Sell |
148,849
-114,489
| -43% | -$859K | 0.02% | 777 |
|
|
2024
Q4 | $1.98M | Sell |
263,338
-8,401
| -3% | -$63.2K | 0.04% | 513 |
|
|
2024
Q3 | $2.07M | Buy |
271,739
+71,539
| +36% | +$544K | 0.04% | 501 |
|
|
2024
Q2 | $1.24M | Buy |
+200,200
| New | +$1.24M | 0.02% | 720 |
|
|
2024
Q1 | – | Sell |
-128,771
| Closed | -$771K | – | 1896 |
|
|
2023
Q4 | $771K | Sell |
128,771
-276,142
| -68% | -$1.65M | 0.02% | 836 |
|
|
2023
Q3 | $2.87M | Buy |
404,913
+319,037
| +372% | +$2.26M | 0.11% | 250 |
|
|
2023
Q2 | $605K | Sell |
85,876
-227,665
| -73% | -$1.6M | 0.02% | 936 |
|
|
2023
Q1 | $2.61M | Buy |
+313,541
| New | +$2.61M | 0.11% | 299 |
|
|
2022
Q1 | – | Sell |
-33,300
| Closed | -$461K | – | 1552 |
|
|
2021
Q4 | $461K | Buy |
+33,300
| New | +$461K | 0.03% | 689 |
|
|
2021
Q2 | – | Sell |
-19,105
| Closed | -$194K | – | 1084 |
|
|
2021
Q1 | $194K | Buy |
+19,105
| New | +$194K | 0.02% | 766 |
|
|
2020
Q4 | – | Sell |
-191,283
| Closed | -$657K | – | 951 |
|
|
2020
Q3 | $657K | Buy |
+191,283
| New | +$657K | 0.13% | 244 |
|